Synapse - Genovefa Papanicolaou

Search Within

Genovefa A Papanicolaou

Results (242)

CMV outcomes and health care resource utilization in CMV-seropositive (R+) hematopoietic stem cell transplant (HCT) recipients managed with pre-emptive therapy (PET)

Meeting Abstract

Fang, J.; Zavras, P. D.; Su, Y.; Raval, A. D.; Tang, Y.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
Bone Marrow Transplantation (2019)

Fulltext@MSK | Save

Letermovir in hematopoietic cell transplantation: Beyond the label

Meeting Abstract

Lin, A.; Maloy, M. A.; Bhatt, V.; DeRespiris, L.; Griffin, M.; Lau, C.; Proli, A. J.; Barker, J. N.; Shaffer, B. C.; Giralt, S. A.; more...
Bone Marrow Transplantation (2019)

Fulltext@MSK | Save

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1

Journal Article

Ustun, C.; Kim, S.; Chen, M.; Beitinjaneh, A. M.; Brown, V. I.; Dahi, P. B.; Daly, A.; Diaz, M. A.; Freytes, C. O.; Ganguly, S.; more...
Blood Advances (2019)

Fulltext@MSK | Save

Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation

Journal Article

Ustun, C.; Young, J. A. H.; Papanicolaou, G. A.; Kim, S.; Ahn, K. W.; Chen, M.; Abdel-Azim, H.; Aljurf, M.; Beitinjaneh, A.; Brown, V.; more...
Bone Marrow Transplantation (2019)

Fulltext@MSK | Save

Cytomegalovirus infection in allogeneic hematopoietic cell transplantation managed by the preemptive approach: Estimating the impact on healthcare resource utilization and outcomes

Journal Article

Huang, Y. T.; Su, Y.; Kim, S. J.; Nichols, P.; Burack, D.; Maloy, M.; Giralt, S.; Perales, M. A.; Jakubowski, A. A.; Papanicolaou, G. A.
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Impact of empiric treatment for vancomycin-resistant enterococcus in colonized patients early after allogeneic hematopoietic stem cell transplantation

Journal Article

Kamboj, M.; Cohen, N.; Huang, Y. T.; Kerpelev, M.; Jakubowski, A.; Sepkowitz, K. A.; Papanicolaou, G. A.; Seo, S. K.
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study

Journal Article

Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Uknis, M.; Wijatyk, A.; Wu, J.; Boeckh, M.; Marty, F. M.; more...
Clinical Infectious Diseases (2019)

Fulltext@MSK | Save

A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplantation

Journal Article

Marty, F. M.; Winston, D. J.; Chemaly, R. F.; Mullane, K. M.; Shore, T. B.; Papanicolaou, G. A.; Chittick, G.; Brundage, T. M.; Wilson, C.; Morrison, M. E.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients

Journal Article

Lee, Y. J.; Neofytos, D.; Kim, S. J.; Cheteyan, L.; Huang, Y. T.; Papadopoulos, E. B.; Jakubowski, A. A.; Papanicolaou, G. A.
Transplant Infectious Disease (2018)

Fulltext@MSK | Save

Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation

Journal Article

Rosillo, C.; Avila, A. M.; Huang, Y. T.; Devlin, S.; Cho, C.; Montoro, J.; Maloy, M. A.; Papanicolaou, G. A.; Barba, P.; Perales, M. A.
Transplant Infectious Disease (2018)

Fulltext@MSK | Save